Elucidating the role of RNA splicing in the metastatic seeding and outgrowth of aggressive cancers.

阐明 RNA 剪接在侵袭性癌症的转移播种和生长中的作用。

基本信息

  • 批准号:
    10665061
  • 负责人:
  • 金额:
    $ 4.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-13 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Metastasis is the process in which disseminated tumor cells (DTCs) spread to distal tissues and organs, and it is the leading cause of cancer-related deaths. In order to complete the metastatic cascade, DTCs must be able to invade distal sites, initiate tumor growth, proliferate, and promote a tumor microenvironment (TME) to evade immune surveillance and promote angiogenesis. Elucidating novel mechanisms that underlie these metastatic phenotypes in DTCs can identify key drivers of metastasis, as well as potential therapeutic vulnerabilities which can better target metastatic tumors. My dissertation research focuses on elucidating the mechanisms in which the lncRNA BORG (BMP/OP-Responsive Gene) drives breast cancer (BC) metastasis. My studies determined that metastatic BC cells are reliant upon BORG complexing with E3 SUMO ligase TRIM28 to induce breast cancer stem cells (BCSCs) to expand and self-renew both in vitro and in vivo. This work establishes BORG as a novel driver of BCSCs, and therefore increases our understanding of the mechanisms driving the accumulation of these malignant cell populations. My recent preliminary data suggests BORG:TRIM28 complexes downregulate the expression of splicing factors in BC cells, which contributes to BCSC phenotypes. Interestingly, accumulating evidence indicates that dysregulation of RNA splicing, a complex molecular tool that can control cellular phenotypes through transcriptomic regulatory mechanisms, contributes to a variety of tumorigenic phenotypes and even metastatic relapse. Therefore, during the F99 portion of this proposal, I seek to elucidate the mechanism whereby BORG:TRIM28 complexes dysregulate RNA splicing operant in driving metastatic and BCSC phenotypes in BC. To complete this research during my dissertation, I will (i) determine which splicing factors dysregulated by BORG:TRIM28 complexes drive metastatic phenotypes in BC in vitro and in vivo, and (ii) use RNAseq and subsequent validation to determine the specific alternative splicing events affected by a subset of these splicing factors in BORG-expressing cells. This work will identify novel mechanisms of RNA splicing regulation that play key roles in metastatic phenotypes of BC cells. During the K00 phase of this proposal, I plan to work closely with my postdoctoral mentor to elucidate the mechanisms in which RNA splicing contributes to tumor cell crosstalk with the TME to promote immune evasion and subsequent metastatic outgrowth. Specifically, I plan to elucidate (i) how alternative splicing in tumor cells drive changes in the metastatic TME to promote immune evasion, and (ii) how alternative splicing changes in TME cells, such as T cells and fibroblasts, contribute to the metastatic niche and subsequent metastatic outgrowth. The current and future goals of my research are to elucidate mechanisms in which dysregulated RNA splicing contributes to metastatic seeding and outgrowth in aggressive cancers. My predoctoral and postdoctoral research will provide me with expertise in the role of RNA splicing in cancer metastasis, and provide me with essential research and professional skills to launch me into my independent research career at a leading research institute.
项目摘要/摘要 转移是传播肿瘤细胞(DTC)扩散到远端组织和器官的过程,它 是与癌症相关死亡的主要原因。为了完成转移级联,DTC必须能够 入侵远端部位,启动肿瘤生长,增殖并促进肿瘤微环境(TME)以逃避 免疫监测并促进血管生成。阐明这些转移性基础的新型机制 DTC中的表型可以识别转移的关键动力,以及潜在的治疗脆弱性 可以更好地靶向转移性肿瘤。我的论文研究重点是阐明 lncrna borg(BMP/OP响应基因)驱动乳腺癌(BC)转移。我的研究确定 该转移性BC细胞依赖于Borg与E3 Sumo连接酶Trim28的络合 癌症干细胞(BCSC)在体外和体内扩展和自我更新。这项工作确立了博格 BCSC的新型驱动力,因此增加了我们对推动积累机制的理解 这些恶性细胞群体。我最近的初步数据建议BORG:TRIM28复合物 在BC细胞中下调剪接因子的表达,这有助于BCSC表型。有趣的是, 累积证据表明RNA剪接的失调,这是一种可以控制的复杂分子工具 通过转录组调节机制的细胞表型有助于多种肿瘤性 表型,甚至转移性复发。因此,在本提案的F99部分中,我试图阐明 Borg:TRIM28复合物在驱动转移和 卑诗省的BCSC表型。为了在论文期间完成这项研究,我将(i)确定哪个剪接 BORG失调的因素:TRIM28络合物驱动体外和体内卑诗省转移性表型,以及 (ii)使用RNASEQ和后续验证来确定受A影响的特定替代剪接事件 这些剪接因子的子集在表达Borg的细胞中。这项工作将确定RNA的新型机制 剪接调节在BC细胞的转移性表型中起关键作用。在此提案的K00阶段, 我计划与博士后导师紧密合作,以阐明RNA剪接贡献的机制 与TME串扰肿瘤细胞,以促进免疫逃避和随后的转移生长。 具体而言,我计划阐明(i)肿瘤细胞中的替代剪接如何驱动转移性TME的变化到 促进免疫逃避,以及(ii)TME细胞(例如T细胞和成纤维细胞)中的替代剪接如何变化 有助于转移性利基和随后的转移生长。我的当前和未来目标 研究旨在阐明失调的RNA剪接有助于转移播和 侵略性癌症的生长。我的主要和博士后研究将为我提供专业知识 RNA剪接在癌症转移中的作用,并为我提供基本的研究和专业技能 将我启动到我在一家领先的研究所的独立研究生涯中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kimberly Parker其他文献

Kimberly Parker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kimberly Parker', 18)}}的其他基金

Elucidating the role of RNA splicing in the metastatic seeding and outgrowth of aggressive cancers.
阐明 RNA 剪接在侵袭性癌症的转移播种和生长中的作用。
  • 批准号:
    10527482
  • 财政年份:
    2022
  • 资助金额:
    $ 4.32万
  • 项目类别:
IncRNA BORG Mediates Alternative Splicing to Enhance Cellular Plasticity in TNBC
IncRNA BORG 介导选择性剪接以增强 TNBC 中的细胞可塑性
  • 批准号:
    10153025
  • 财政年份:
    2021
  • 资助金额:
    $ 4.32万
  • 项目类别:
IncRNA BORG Mediates Alternative Splicing to Enhance Cellular Plasticity in TNBC
IncRNA BORG 介导选择性剪接以增强 TNBC 中的细胞可塑性
  • 批准号:
    10350611
  • 财政年份:
    2021
  • 资助金额:
    $ 4.32万
  • 项目类别:

相似国自然基金

海洋缺氧对持久性有机污染物入海后降解行为的影响
  • 批准号:
    42377396
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
  • 批准号:
    32371616
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
  • 批准号:
    22379027
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
  • 批准号:
    32300624
  • 批准年份:
    2023
  • 资助金额:
    10 万元
  • 项目类别:
    青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
  • 批准号:
    52377215
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
  • 批准号:
    10648346
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
  • 批准号:
    10750357
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
Data Core
数据核心
  • 批准号:
    10806551
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
Understanding the Role of GARP Proteins in Rod Outer Segment Disc Formation and Retinal Degeneration
了解 GARP 蛋白在视杆外节盘形成和视网膜变性中的作用
  • 批准号:
    10748725
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
  • 批准号:
    10673458
  • 财政年份:
    2023
  • 资助金额:
    $ 4.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了